Luxna Biotech Co., Ltd.

  • EN
  • JP

Luxna Biotech Co., Ltd.

  • About
  • Oligonucleotide Therapeutics
  • Technology
  • Business Structure
  • News
  • Open Positions
  • Access
  • Contact
ルクサナバイオテク株式会社
  • About
  • Oligonucleotide Therapeutics
  • Technology
  • Business Structure
  • News
  • Open Positions
  • Access
  • Contact

News

  1. HOME
  2. News

Exhibiting at BioJapan 2025

  • 2025/09/18
  • Event
Read

Notice Regarding Reduction in Share Capital

  • 2025/09/09
  • Notice
Read

We will exhibit at Global Startup EXPO 2025

  • 2025/09/05
  • Event
Read

Our President and CEO, Mr. Hideaki Sato will give a presentation at RNA World 2025

  • 2025/08/29
  • Event
Read

Presentation at the 5th Oligonucleotides for CNS Summit in Boston, USA

  • 2025/08/20
  • Event
Read

Luxna Biotech selected as first-phase supported startup in Nakanoshima Qross Cluster Program

  • 2025/08/19
  • Event
Read

Announcement of Second Close of Series C Funding Round

  • 2025/08/07
  • Notice
Read

Poster Presentations at the 10th Annual Meeting of the Nucleic Acids Therapeutics Society of Japan

  • 2025/06/13
  • Event
Read

Participation in the BIO International Convention in Boston, USA

  • 2025/05/13
  • Event
Read

Presentation at TIDES US 2025 in San Diego, USA

  • 2025/05/07
  • Event
Read
  • 1
  • 2
  • 3
  • Next

Luxna Biotech Co., Ltd.

  • C907 9F Bldg. C, Techno-Alliance Complex, 2-8 Yamadaoka, Suita, Osaka 565-0871 JAPAN
  • TEL: +81(0)6-6170-1228
  • FAX: +81(0)6-6170-2207
  • MAIL: info@luxnabiotech.co.jp
  • About
  • Oligonucleotide Therapeutics
  • Technology
  • Business Structure
  • News
  • Open Positions
  • Company Overview
  • Contact
  • Animal Experiments Policy
  • Privacy Protection Policy
  • Site Map

Copyright © 2018 Luxna Biotech Co., Ltd. All Rights Reserved.